Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
Authors
Keywords
-
Journal
BRAIN
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-02-23
DOI
10.1093/brain/awac077
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia
- (2021) Jessica L Panman et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Combination of serum and CSF neurofilament-light and neuroinflammatory biomarkers to evaluate ALS
- (2021) Alexandre Brodovitch et al. Scientific Reports
- Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration
- (2021) Julio C. Rojas et al. NEUROLOGY
- Identifying individuals with high risk of Alzheimer’s disease using polygenic risk scores
- (2021) Ganna Leonenko et al. Nature Communications
- A multicentre validation study of the diagnostic value of plasma neurofilament light
- (2021) Nicholas J. Ashton et al. Nature Communications
- Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics
- (2021) Arvin Behzadi et al. Scientific Reports
- Urinary p75ECD levels in patients with amyotrophic lateral sclerosis: a meta-analysis
- (2021) Guanzhong Shi et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis
- (2020) Samir Abu-Rumeileh et al. JOURNAL OF NEUROLOGY
- Cross-sectional and longitudinal measures of chitinase proteins in amyotrophic lateral sclerosis and expression of CHI3L1 in activated astrocytes
- (2020) Lucas Vu et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with C9orf72 hexanucleotide repeat expansion
- (2020) Peggy Barschke et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
- (2020) Carolin Heller et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis
- (2020) Gorka FernÁndez-Eulate et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype
- (2020) Ione O.C. Woollacott et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Metabolomic changes associated with frontotemporal lobar degeneration syndromes
- (2020) Alexander G. Murley et al. JOURNAL OF NEUROLOGY
- The involvement of regulatory T cells in amyotrophic lateral sclerosis and their therapeutic potential
- (2020) I. Giovannelli et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis
- (2020) Antti Cajanus et al. Annals of Clinical and Translational Neurology
- Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration
- (2020) Alberto Benussi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
- (2020) Timothy Miller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation
- (2020) Jared S. Katzeff et al. Scientific Reports
- Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers
- (2020) Julia Remnestål et al. Translational Neurodegeneration
- Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration
- (2020) Alberto Benussi et al. JOURNAL OF ALZHEIMERS DISEASE
- Frontotemporal dementia: Plasma metabolomic signature using gas chromatography–mass spectrometry
- (2020) Anna Luiza Morais Santos et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- CSF Neurofilament Light Chain Elevation Predicts ALS Severity and Progression
- (2020) Qionghua Sun et al. Frontiers in Neurology
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease
- (2019) Oliver Preische et al. NATURE MEDICINE
- Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics
- (2019) Emma L. van der Ende et al. Annals of Clinical and Translational Neurology
- The ALS-FTD-linked gene product, C9orf72, regulates neuronal morphogenesis via autophagy
- (2019) Wan Yun Ho et al. Autophagy
- Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest
- (2019) Martha S Foiani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurofilament light chain as a biomarker in neurological disorders
- (2019) Lorenzo Gaetani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neuroinflammation in frontotemporal dementia
- (2019) Fiona Bright et al. Nature Reviews Neurology
- Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
- (2019) Claire Bridel et al. JAMA Neurology
- Neurofilament light chain as an indicator of exacerbation prior to clinical symptoms in multiple sclerosis
- (2019) Keith R. Edwards et al. Multiple Sclerosis and Related Disorders
- Neurofilaments in pre-symptomatic ALS and the impact of genotype
- (2019) Michael Benatar et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis
- (2019) Patrick Oeckl et al. ACTA NEUROPATHOLOGICA
- Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study
- (2019) Emma L van der Ende et al. LANCET NEUROLOGY
- TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis
- (2018) Vivek Majumder et al. BMC Neurology
- Tau filaments in neurodegenerative diseases
- (2018) Michel Goedert FEBS LETTERS
- Involvement of cystatin C in immunity and apoptosis
- (2018) Mengting Zi et al. IMMUNOLOGY LETTERS
- Primary progressive aphasia: a clinical approach
- (2018) Charles R. Marshall et al. JOURNAL OF NEUROLOGY
- Plasma tau is increased in frontotemporal dementia
- (2018) Martha S Foiani et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Brain-related proteins as potential CSF biomarkers of Alzheimer's disease: A targeted mass spectrometry approach
- (2018) Ilijana Begcevic et al. Journal of Proteomics
- Towards a TDP-43-Based Biomarker for ALS and FTLD
- (2018) Emily Feneberg et al. MOLECULAR NEUROBIOLOGY
- Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons
- (2018) Yingxiao Shi et al. NATURE MEDICINE
- Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum
- (2018) Lieke H.H. Meeter et al. NEUROLOGY
- Genetic risk for neurodegenerative disorders, and its overlap with cognitive ability and physical function
- (2018) Saskia P. Hagenaars et al. PLoS One
- A Modified Reading the Mind in the Eyes Test Predicts Behavioral Variant Frontotemporal Dementia Better Than Executive Function Tests
- (2018) Matthias L. Schroeter et al. Frontiers in Aging Neuroscience
- Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects
- (2018) Zhouwei Xu et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Lipidomics Analysis of Behavioral Variant Frontotemporal Dementia: A Scope for Biomarker Development
- (2018) Woojin Scott Kim et al. Frontiers in Neurology
- Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers
- (2018) Lieke H.H. Meeter et al. Annals of Clinical and Translational Neurology
- YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
- (2018) Pol Andrés-Benito et al. Aging-US
- Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase
- (2018) Patrick Oeckl et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurofilaments as biomarkers in neurological disorders
- (2018) Michael Khalil et al. Nature Reviews Neurology
- CSF pro-orexin and amyloid-β38 expression in Alzheimer’s disease and frontotemporal dementia
- (2018) Wendy E. Heywood et al. NEUROBIOLOGY OF AGING
- Novel CSF biomarkers to discriminate FTLD and its pathological subtypes
- (2018) Marta del Campo et al. Annals of Clinical and Translational Neurology
- Inflammation in ALS/FTD pathogenesis
- (2018) Madelyn E. McCauley et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study
- (2018) Samir Abu-Rumeileh et al. JOURNAL OF ALZHEIMERS DISEASE
- Machine Learning Reveals Protein Signatures in CSF and Plasma Fluids of Clinical Value for ALS
- (2018) Michael S. Bereman et al. Scientific Reports
- Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis
- (2017) Peggy Barschke et al. Expert Review of Proteomics
- Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer’s disease and other neurodegenerative diseases
- (2017) Filippo Baldacci et al. Expert Review of Proteomics
- Amyotrophic lateral sclerosis
- (2017) Michael A van Es et al. LANCET
- Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis
- (2017) Yuri Ciervo et al. Molecular Neurodegeneration
- Imaging and fluid biomarkers in frontotemporal dementia
- (2017) Lieke H. Meeter et al. Nature Reviews Neurology
- Frontotemporal Dementia
- (2017) Nicholas T. Olney et al. NEUROLOGIC CLINICS
- A Primer on Concepts and Applications of Proteomics in Neuroscience
- (2017) Fabian Hosp et al. NEURON
- Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72 -associated amyotrophic lateral sclerosis
- (2017) Tania F. Gendron et al. Science Translational Medicine
- Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival
- (2017) Tobias Skillbäck et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Unraveling the Role of RNA Mediated Toxicity of C9orf72 Repeats in C9-FTD/ALS
- (2017) Vijay Kumar et al. Frontiers in Neuroscience
- Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Sclerosis in a Chinese cohort
- (2017) Rui Jia et al. Scientific Reports
- Motor neuron disease: biomarker development for an expanding cerebral syndrome
- (2016) M. R. Turner CLINICAL MEDICINE
- Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation
- (2016) Kohsuke Kanekura et al. HUMAN MOLECULAR GENETICS
- Glial fibrillary acidic protein as a marker of astrocytic activation in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis
- (2016) Felix Benninger et al. JOURNAL OF CLINICAL NEUROSCIENCE
- The clinical spectrum of sporadic and familial forms of frontotemporal dementia
- (2016) Ione O. C. Woollacott et al. JOURNAL OF NEUROCHEMISTRY
- Genetics of FTLD: overview and what else we can expect from genetic studies
- (2016) Cyril Pottier et al. JOURNAL OF NEUROCHEMISTRY
- Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum
- (2016) Carlo Wilke et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The frontotemporal dementia-motor neuron disease continuum
- (2016) James R Burrell et al. LANCET
- Decoding ALS: from genes to mechanism
- (2016) J. Paul Taylor et al. NATURE
- C9orf72 is required for proper macrophage and microglial function in mice
- (2016) J. G. ORourke et al. SCIENCE
- Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease
- (2016) Aaron Burberry et al. Science Translational Medicine
- Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis
- (2016) YAN CHEN et al. Experimental and Therapeutic Medicine
- C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production and glomerulonephropathy in mice
- (2016) Amanda Atanasio et al. Scientific Reports
- The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients
- (2015) Zhengrui Xi et al. ACTA NEUROPATHOLOGICA
- Jump from Pre-mutation to Pathologic Expansion in C9orf72
- (2015) Zhengrui Xi et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration
- (2015) Aiko Ishiki et al. JOURNAL OF NEUROCHEMISTRY
- Label-Free LC–MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis
- (2015) Mahlon A. Collins et al. JOURNAL OF PROTEOME RESEARCH
- Neurofilament light chain level in cerebrospinal fluid can differentiate Parkinson's disease from atypical parkinsonism: Evidence from a meta-analysis
- (2015) Wataru Sako et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Frontotemporal dementia
- (2015) Jee Bang et al. LANCET
- Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD)
- (2015) Serena Lattante et al. TRENDS IN GENETICS
- Estimating the burden of early onset dementia; systematic review of disease prevalence
- (2014) M. A. Lambert et al. EUROPEAN JOURNAL OF NEUROLOGY
- Frontotemporal lobar degeneration—building on breakthroughs
- (2014) Julie van der Zee et al. Nature Reviews Neurology
- SOD1 Function and Its Implications for Amyotrophic Lateral Sclerosis Pathology
- (2014) Rosie K. A. Bunton-Stasyshyn et al. NEUROSCIENTIST
- The Extracellular Domain of Neurotrophin Receptor p75 as a Candidate Biomarker for Amyotrophic Lateral Sclerosis
- (2014) Stephanie R. Shepheard et al. PLoS One
- Specific Changes of Serum Proteins in Parkinson's Disease Patients
- (2014) Wenwen Lu et al. PLoS One
- Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia
- (2014) Barbara Borroni et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases
- (2014) Emily Feneberg et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Phosphorylated Tau as a Candidate Biomarker for Amyotrophic Lateral Sclerosis
- (2014) Murray Grossman et al. JAMA Neurology
- Plasma profiling reveals three proteins associated to amyotrophic lateral sclerosis
- (2014) Anna Häggmark et al. Annals of Clinical and Translational Neurology
- Is SOD1 loss of function involved in amyotrophic lateral sclerosis?
- (2013) Rachele A. Saccon et al. BRAIN
- Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation
- (2013) M. Suarez-Calvet et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- State of play in amyotrophic lateral sclerosis genetics
- (2013) Alan E Renton et al. NATURE NEUROSCIENCE
- Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP
- (2013) W. T. Hu et al. NEUROLOGY
- Alterations of CSF Cystatin C Levels and Their Correlations with CSF Αβ40 and Αβ42 Levels in Patients with Alzheimer's Disease, Dementia with Lewy Bodies and the Atrophic Form of General Paresis
- (2013) Xiao-Mei Zhong et al. PLoS One
- Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease
- (2013) David J. Irwin et al. Frontiers in Aging Neuroscience
- YKL-40, a Chitinase-like Protein at the Intersection of Inflammation and Remodeling
- (2012) Chun Geun Lee et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Neurofilaments at a glance
- (2012) A. Yuan et al. JOURNAL OF CELL SCIENCE
- Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis
- (2012) K. B. Boylan et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms
- (2012) Weihua Zhao et al. NEUROBIOLOGY OF DISEASE
- Monitoring CSF Proteome Alterations in Amyotrophic Lateral Sclerosis: Obstacles and Perspectives in Translating a Novel Marker Panel to the Clinic
- (2012) Nils von Neuhoff et al. PLoS One
- TDP-43: gumming up neurons through protein–protein and protein–RNA interactions
- (2012) Emanuele Buratti et al. TRENDS IN BIOCHEMICAL SCIENCES
- SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy
- (2012) Leah Winer et al. JAMA Neurology
- Alterations of T cell subsets in ALS: a systemic immune activation?
- (2011) M. Rentzos et al. ACTA NEUROLOGICA SCANDINAVICA
- Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
- (2011) David R. Beers et al. BRAIN
- Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients
- (2011) Per Zetterström et al. JOURNAL OF NEUROCHEMISTRY
- Amyotrophic lateral sclerosis
- (2011) Matthew C Kiernan et al. LANCET
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
- (2011) Mariely DeJesus-Hernandez et al. NEURON
- A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
- (2011) Alan E. Renton et al. NEURON
- GFAP in health and disease
- (2011) J. Middeldorp et al. PROGRESS IN NEUROBIOLOGY
- TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia
- (2010) Ian RA Mackenzie et al. LANCET NEUROLOGY
- Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics
- (2010) Henrik Ryberg et al. MUSCLE & NERVE
- TARDBP Mutations in Frontotemporal Lobar Degeneration: Frequency, Clinical Features, and Disease Course
- (2010) B. Borroni et al. REJUVENATION RESEARCH
- YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
- (2009) Camilla N Rathcke et al. Cardiovascular Diabetology
- Cystatin C in cerebrospinal fluid as a biomarker of ALS
- (2009) Sachiko Tsuji-Akimoto et al. NEUROSCIENCE LETTERS
- Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS)
- (2009) Johannes Brettschneider et al. NEUROSCIENCE LETTERS
- Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis
- (2008) Takashi Kasai et al. ACTA NEUROPATHOLOGICA
- Proteome Analysis of Cerebrospinal Fluid in Amyotrophic Lateral Sclerosis (ALS)
- (2008) Johannes Brettschneider et al. NEUROCHEMICAL RESEARCH
- Bunina bodies in amyotrophic lateral sclerosis
- (2008) Koichi Okamoto et al. NEUROPATHOLOGY
- Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease
- (2007) Emanuele Buratti Frontiers in Bioscience-Landmark
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started